Burger line Burger line Burger line
Logo Logo Logo
Burger line Burger line Burger line
Menu
Sign in
Sign in

Israel's Healthy.io raises $60 million, gets FDA ok for urine test

TEL AVIV (Reuters) - Israel’s Healthy.io said on Thursday it raised $60 million in funding and received clearance from the U.S. Food and Drug Administration for its smartphone-based urine albumin test to aid in diagnosing chronic kidney disease.

The funding round was led by Corner Ventures with participation by Joy Capital Ventures and previous investors Ansonia Holdings, Aleph and Samsung NEXT. The company has raised $95 million to date.

The funds will be used to accelerate Healthy.io’s global expansion and product development.

“The smartphone has the potential to be the great equalizer of healthcare,” said Yonatan Adiri, founder and CEO of Healthy.io.

This is the company’s second FDA clearance. Last year it received clearance for its at-home, smartphone-based urinalysis test kit and now has a partnership with Boots UK, placing its test kits in hundreds of pharmacies.

Sep 11, 2019

https://www.reuters.com/

0 items in Cart
Cart Subtotal:
Go to cart
You will be able to Pay Online or Request a Quote
Catalog
Services
Company

We use "cookies*  to ensure the functionality of our website, recognise your browser or device, learn more about your interests, and provide you with essential features and services and for additional purposes, including:

Recognising you when you sign-in to use our services. This allows us to provide you with product recommendations, display personalised content, and provide other customised features and services.
Keeping track of your specified preferences. You may set your preferences through Your Account..
Keeping track of items stored in your shopping basket and personal cabinet.
Conducting research and diagnostics to improve ChemDiv’s content, products, and services.
Delivering content, including ads, relevant to your interests on ChemDiv’s site
Reporting. This allows us to measure and analyse the performance of our services.

By  cookies you give consent to the processing of your personal data, including transfer to third parties. Further information can be found in our privacy policy.

Accept all cookies